Development of 3D printed electrospun vascular graft loaded with tetramethylpyrazine for reducing thrombosis and restraining aneurysmal dilatation

Abstract

Background: Small-diameter vascular grafts have become the focus of attention in tissue engineering. Thrombosis and aneurysmal dilatation are the two major complications of the loss of vascular access after surgery. Therefore, we focused on fabricating 3D printed electrospun vascular grafts loaded with tetramethylpyrazine (TMP) to overcome these limitations. Methods: Based on electrospinning and 3D printing, 3D-printed electrospun vascular grafts loaded with TMP were fabricated. The inner layer of the graft was composed of electrospun poly(L-lactic-co-caprolactone) (PLCL) nanofibers and the outer layer consisted of 3D printed polycaprolactone (PCL) microfibers. The characterization and mechanical properties were tested. The blood compatibility and in vitro cytocompatibility of the grafts were also evaluated. Additionally, rat abdominal aortas were replaced with these 3D-printed electrospun grafts to evaluate their biosafety. Results: Mechanical tests demonstrated that the addition of PCL microfibers could improve the mechanical properties. In vitro experimental data proved that the introduction of TMP effectively inhibited platelet adhesion. Afterwards, rat abdominal aorta was replaced with 3D-printed electrospun grafts. The 3D-printed electrospun graft loaded with TMP showed good biocompatibility and mechanical strength within 6 months and maintained substantial patency without the occurrence of acute thrombosis. Moreover, no obvious aneurysmal dilatation was observed. Conclusions: The study demonstrated that 3D-printed electrospun vascular grafts loaded with TMP may have the potential for injured vascular healing.

Keywords

3D printing / Electrospinning / Tetramethylpyrazine / Thrombosis / Aneurysmal dilatation / Vascular graft

References

[1] Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The Global Burden of Cardiovascular Diseases and Risk. J Am Coll Cardiol. 2022; 80: 2361-71.

[2] Allison M, Armstrong D, Goodney P, Hamburg N, Kirksey L, Lancaster K, et al. Health Disparities in Peripheral Artery Disease: A Scientific Statement From the American Heart Association. Circulation. 2023; 148: 286-96.

[3] Wang Y, Li G, Yang L, Luo R, Guo G. Development of Innovative Biomaterials and Devices for the Treatment of Cardiovascular Diseases. Adv Mater. 2022; 34: e2201971.

[4] Cho S, Discher D, Leong K, Vunjak-Novakovic G, Wu J. Challenges and opportunities for the next generation of cardiovascular tissue engineering. Nat Methods. 2022; 19: 1064-71.

[5] Jaffer I, Fredenburgh J, Hirsh J, Weitz J. Medical device-induced thrombosis: what causes it and how can we prevent it? J Thromb Haemost. 2015; 13 Suppl 1: S72-81.

[6] Gawaz M, Geisler T, Borst O. Current concepts and novel targets for antiplatelet therapy. Nat Rev Cardiol. 2023; 20: 583-99.

[7] Niklason L, Lawson J. Bioengineered human blood vessels. Science. 2020; 370: eaaw8682.

[8] Chen Z, Zhang C, Gao F, Fu Q, Fu C, He Y, et al. A systematic review on the rhizome of Ligusticum chuanxiong Hort. (Chuanxiong). Food Chem Toxicol. 2018; 119: 309-25.

[9] Li D, Long Y, Yu S, Shi A, Wan J, Wen J, et al. Research Advances in Cardio-Cerebrovascular Diseases of Ligusticum chuanxiong Hort. Front Pharmacol. 2022; 12: 832673.

[10] Chen Y, Lu W, Yang K, Duan X, Li M, Chen X, et al. Tetramethylpyrazine: a promising drug for the treatment of pulmonary hypertension. Br J Pharmacol. 2020; 177: 2743-64.

[11] Xu T, Chen G, Tong X, Wu Y, Xu H, Han X, et al. Tetramethylpyrazine: A review of the most recent research. Pharmacol Res-Mod Chin Med. 2022; 5: 100171.

[12] Lin J, Wang Q, Zhou S, Xu S, Yao K. Tetramethylpyrazine: A review on its mechanisms and functions. Biomed Pharmacother. 2022; 150: 113005.

[13] Wilson WR, Bower TC, Creager MA, Amin-Hanjani S, O’Gara PT, Lockhart PB, et al. Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the American Heart Association. Circulation. 2016; 134: e412-60.

[14] Wang Z, Liu L, Mithieux SM, Weiss AS. Fabricating organized elastin in vascular grafts. Trends Biotechnol. 2021; 39: 505-18.

[15] Rohringer S, Grasl C, Ehrmann K, Hager P, Hahn C, Specht SJ, et al. Biodegradable, Self-Reinforcing Vascular Grafts for In Situ Tissue Engineering Approaches. Adv Healthc Mater. 2023; 12: e2300520.

[16] Carrabba M, Madeddu P. Current strategies for the manufacture of small size tissue engineering vascular grafts. Front Bioeng Biotechnol. 2018; 6: 41.

[17] Zhi D, Cheng Q, Midgley AC, Zhang Q, Wei T, Li Y, et al. Mechanically reinforced biotubes for arterial replacement and arteriovenous grafting inspired by architectural engineering. Sci Adv. 2022; 8: eabl3888.

[18] Zhu T, Gu H, Ma W, Zhang Q, Du J, Chen S, et al. A fabric reinforced small diameter tubular graft for rabbits’ carotid artery defect. Compos Part B-Eng. 2021; 225: 109274.

[19] Lee HS, Jeon EY, Nam JJ, Park JH, Choi IC, Kim SH, et al. Development of a regenerative porous PLCL nerve guidance conduit with swellable hydrogel-based microgrooved surface pattern via 3D printing. Acta Biomater. 2022; 141: 219-32.

[20] Kuang H, Wang Y, Shi Y, Yao W, He X, Liu X, et al. Construction and performance evaluation of Hep/silk-PLCL composite nanofiber small-caliber artificial blood vessel graft. Biomaterials. 2020; 259: 120288.

[21] Xie X, Chen Y, Wang X, Xu X, Shen Y, Khan AR, et al. Electrospinning nanofiber scaffolds for soft and hard tissue regeneration. J Mater Sci Technol. 2020; 59: 243-61.

[22] Shen Y, Cui J, Yu X, Song J, Cai P, Guo W, et al. Recent advances in three-dimensional printing in cardiovascular devices: Bench and bedside applications. Smart Mater Med. 2024; 5: 36-51.

[23] Yadid M, Oved H, Silberman E, Dvir T. Bioengineering approaches to treat the failing heart: from cell biology to 3D printing. Nat Rev Cardiol. 2022; 19: 83-99.

[24] Guzzi E, Tibbitt M. Additive Manufacturing of Precision Biomaterials. Adv Mater. 2020; 32: e1901994.

[25] Norouzi SK, Shamloo A. Bilayered heparinized vascular graft fabricated by combining electrospinning and freeze drying methods. Mater Sci Eng C Mater Biol Appl. 2019; 94: 1067-76.

[26] Zhuang Y, Zhang C, Cheng M, Huang J, Liu Q, Yuan G, et al. Challenges and strategies for in situ endothelialization and long-term lumen patency of vascular grafts. Bioact Mater. 2021; 6: 1791-809.

[27] Sang Y, Roest M, de Laat B, de Groot PG, Huskens D. Interplay between platelets and coagulation. Blood Rev. 2021; 46: 100733.

[28] Gupta P, Mandal BB. Tissue-engineered vascular grafts: emerging trends and technologies. Adv Funct Mater. 2021; 31: 2100027.

[29] Weekes A, Bartnikowski N, Pinto N, Jenkins J, Meinert C, Klein TJ. Biofabrication of small diameter tissue-engineered vascular grafts. Acta Biomater. 2022; 138: 92-111.

[30] Drews JD, Pepper VK, Best CA, Szafron JM, Cheatham JP, Yates AR, et al. Spontaneous reversal of stenosis in tissue-engineered vascular grafts. Sci Transl Med. 2020; 12: eaax6919.

[31] Zheng Y, Zeng J, Lin J, Xia Y, He G. Herbal textual research on Chuanxiong Rhizoma in Chinese classical prescriptions. Zhongguo Zhongyao Za Zhi. 2021; 46: 4293-9.

[32] van der Meijden PEJ, Heemskerk JWM. Platelet biology and functions: new concepts and clinical perspectives. Nat Rev Cardiol. 2019; 16: 166-79.

[33] Zhang H, Tang W, Wang S, Zhang J, Fan X. Tetramethylpyrazine inhibits platelet adhesion and inflammatory response in vascular endothelial cells by inhibiting P38 MAPK and NF-κB signaling pathways. Inflammation. 2020; 43: 286-97.

[34] Abdal-Hay A, Bartnikowski M, Hamlet S, Ivanovski S. Electrospun biphasic tubular scaffold with enhanced mechanical properties for vascular tissue engineering. Mater Sci Eng C Mater Biol Appl. 2018; 82: 10-8.

[35] Zhu M, Wu Y, Li W, Dong X, Chang H, Wang K, et al. Biodegradable and elastomeric vascular grafts enable vascular remodeling. Biomaterials. 2018; 183: 306-18.

[36] Wu P, Wang L, Li W, Zhang Y, Wu Y, Zhi D, et al. Construction of vascular graft with circumferentially oriented microchannels for improving artery regeneration. Biomaterials. 2020; 242: 119922.

[37] Zia AW, Liu R, Wu X. Structural design and mechanical performance of composite vascular grafts. Biodes Manuf. 2022; 5: 757-85.

[38] Laubach M, Kobbe P, Hutmacher DW. Biodegradable interbody cages for lumbar spine fusion: Current concepts and future directions. Biomaterials. 2022; 288: 121699.